Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)

CNY 37.71

(-1.33%)

Total Debt Summary of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest annual total debt in 2023 was 446.65 Million CNY , up 73.42% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest quarterly total debt in 2024 Q3 was 466.82 Million CNY , down -4.51% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported annual total debt of 257.55 Million CNY in 2022, up 24.6% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported annual total debt of 206.7 Million CNY in 2021, up 779.61% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported quarterly total debt of 596.05 Million CNY for 2024 Q1, up 33.45% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported quarterly total debt of 476.62 Million CNY for 2024 Q2, down -20.04% from previous quarter.

Annual Total Debt Chart of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Historical Annual Total Debt of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Year Total Debt Total Debt Growth
2023 446.65 Million CNY 73.42%
2022 257.55 Million CNY 24.6%
2021 206.7 Million CNY 779.61%
2020 23.5 Million CNY 48.16%
2019 15.86 Million CNY 225.36%
2018 4.87 Million CNY -80.17%
2017 24.57 Million CNY 0.0%

Peer Total Debt Comparison of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Name Total Debt Total Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 1.58 Billion CNY 71.784%
Yabao Pharmaceutical Group Co., Ltd 209 Million CNY -113.708%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 15.79 Billion CNY 97.172%
Harbin Pharmaceutical Group Co., Ltd. 3.55 Billion CNY 87.45%
Tasly Pharmaceutical Group Co., Ltd 2.95 Billion CNY 84.907%
Zhejiang Medicine Co., Ltd. 801.44 Million CNY 44.269%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 839.84 Million CNY 46.818%
Lionco Pharmaceutical Group Co.,Ltd. 565.61 Million CNY 21.032%
Humanwell Healthcare (Group) Co.,Ltd. 9.94 Billion CNY 95.51%
Ginwa Enterprise (Group) Inc. 10.77 Million CNY -4044.851%
Joincare Pharmaceutical Group Industry Co.,Ltd. 7.4 Billion CNY 93.965%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 175.68 Million CNY -154.231%
China Animal Husbandry Industry Co., Ltd. 1.45 Billion CNY 69.326%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 9.91 Million CNY -4407.046%
Zhejiang Huahai Pharmaceutical Co., Ltd. 7.45 Billion CNY 94.007%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.08 Billion CNY 58.742%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.3 Billion CNY 65.707%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 727.9 Million CNY 38.639%
Chongqing Taiji Industry(Group) Co.,Ltd 4.86 Billion CNY 90.812%
HPGC Renmintongtai Pharmaceutical Corporation 2.33 Billion CNY 80.856%
Nanjing Well Pharmaceutical Group Co.,Ltd. 486.95 Million CNY 8.277%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 995.24 Million CNY 55.121%
Henan Lingrui Pharmaceutical Co., Ltd. 149.26 Million CNY -199.231%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.2 Billion CNY 62.896%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.07 Billion CNY 58.609%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 48.13 Million CNY -827.915%
Zhongzhu Healthcare Holding Co.,Ltd 23.94 Million CNY -1765.568%
Beijing Tongrentang Co., Ltd 3.42 Billion CNY 86.966%
KPC Pharmaceuticals, Inc. 1.17 Billion CNY 61.865%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 17.28 Million CNY -2484.531%
North China Pharmaceutical Company Ltd. 11.72 Billion CNY 96.192%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 462.87 Million CNY 3.505%
Tibet Weixinkang Medicine Co., Ltd. 7.68 Million CNY -5714.164%
China National Medicines Corporation Ltd. 3.15 Billion CNY 85.855%
Zhejiang Hisun Pharmaceutical Co., Ltd. 5.69 Billion CNY 92.153%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.15 Billion CNY 85.824%
ChengDu ShengNuo Biotec Co.,Ltd. 267.22 Million CNY -67.147%
Dali Pharmaceuticalco.,Ltd 23.66 Million CNY -1787.592%
Changchun BCHT Biotechnology Co. 20.47 Million CNY -2081.769%
Zhejiang Shengda Bio-Pharm Co., Ltd. 238.44 Million CNY -87.322%
Shanghai Jiaoda Onlly Co.,Ltd 208.92 Million CNY -113.783%
Jiang Zhong Pharmaceutical Co.,Ltd 56.62 Million CNY -688.806%
Mayinglong Pharmaceutical Group Co., LTD. 380.42 Million CNY -17.409%
Cisen Pharmaceutical Co., Ltd. 170.67 Million CNY -161.699%
Hunan Warrant Pharmaceutical Co.,Ltd 24.18 Million CNY -1747.083%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 35.72 Billion CNY 98.75%
Jianmin Pharmaceutical Group Co.,Ltd. 501.17 Million CNY 10.879%
Hunan Fangsheng Pharmaceutical Co., Ltd. 679.7 Million CNY 34.287%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.78 Billion CNY 74.985%
Guobang Pharma Ltd. 963.26 Million CNY 53.632%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 659.05 Million CNY 32.228%
Kangmei Pharmaceutical Co., Ltd. 255.01 Million CNY -75.148%
Shandong Buchang Pharmaceuticals Co., Ltd. 3.4 Billion CNY 86.898%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.19 Billion CNY 86.005%
Henan Taloph Pharmaceutical Stock Co.,Ltd 819.3 Million CNY 45.484%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 116.7 Million CNY -282.716%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.62 Billion CNY 82.989%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.75 Billion CNY 74.478%
Shanghai Yizhong Pharmaceutical Co., Ltd. 44.02 Million CNY -914.472%
Tibet Rhodiola Pharmaceutical Holding Co. 501.52 Million CNY 10.941%
Sichuan Huiyu Pharmaceutical Co., Ltd. 435.5 Million CNY -2.56%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 443.84 Million CNY -0.634%
CanSino Biologics Inc. 2.71 Billion CNY 83.548%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 705.78 Million CNY 36.715%
Shandong Lukang Pharmaceutical Co.,Ltd. 3.43 Billion CNY 86.998%